Mediolanum International Funds Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$91.7M |
| 2 |
UnitedHealth
UNH
|
+$77M |
| 3 |
Walmart Inc
WMT
|
+$76.2M |
| 4 |
Amazon
AMZN
|
+$61.4M |
| 5 |
Costco
COST
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$49.3M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$48.3M |
| 3 |
ExxonMobil
XOM
|
+$42.7M |
| 4 |
Verizon
VZ
|
+$39.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$38.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.77% |
| 2 | Financials | 10.91% |
| 3 | Healthcare | 10.52% |
| 4 | Communication Services | 9.86% |
| 5 | Industrials | 9.75% |
Similar funds
Mediolanum International Funds's Q2 2026 Portfolio in Review
As of Q2 2026, Mediolanum International Funds held 490 positions worth $11.7B, up 24% from $9.42B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Mediolanum International Funds deployed $546M of net new capital in Q2 2026, opening 59 new positions and adding to 228 existing holdings. Its largest new stake was AstraZeneca: 487,420 shares worth $92.3M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Arista Networks, an estimated $49.3M trimmed.
- Mediolanum International Funds's largest Q2 2026 buy was AstraZeneca: 487,420 shares worth $92.3M.
- Mediolanum International Funds added most to UnitedHealth in Q2 2026, an estimated $77M increase.
- Mediolanum International Funds's biggest Q2 2026 reduction was Arista Networks, cutting an estimated $49.3M.
- Mediolanum International Funds fully exited Advanced Drainage Systems in Q2 2026, selling an estimated $28M.
- Mediolanum International Funds's ten largest holdings make up 33% of its $11.7B portfolio in Q2 2026.
- Mediolanum International Funds opened 59 new positions and closed 38 in Q2 2026.
- Mediolanum International Funds's portfolio value rose 24% quarter-over-quarter to $11.7B.
Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.